You have 9 free searches left this month | for more free features.

Rituximab

Showing 2276 - 2300 of 2,665

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Diabetes, Type 1 Trial in Belgium (ATG-MMF-TAC, ATG-Rituximab-MMF-TAC, ATG-basilixumab-MMF-TAC)

Unknown status
  • Diabetes Mellitus, Type 1
  • Antwerpen, Belgium
  • +3 more
Dec 27, 2013

Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in New Brunswick (rituximab, therapeutic allogeneic

Terminated
  • Leukemia
  • +2 more
  • rituximab
  • therapeutic allogeneic lymphocytes
  • New Brunswick, New Jersey
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Me
Sep 13, 2013

Rituxan in Rheumatoid Arthritis AfterInadequate Response to

Completed
  • Rheumatoid Arthritis
    • Birmingham, Alabama
    • +192 more
    Mar 26, 2015

    B-cell Childhood Acute Lymphoblastic Leukemia, Childhood Burkitt Lymphoma, Childhood Diffuse Large Cell Lymphoma Trial in

    Terminated
    • B-cell Childhood Acute Lymphoblastic Leukemia
    • +8 more
    • Arcadia, California
      Children's Oncology Group
    Oct 7, 2013

    Lymphoma Trial in London (bleomycin sulfate, rituximab, prednisolone)

    Unknown status
    • Lymphoma
    • bleomycin sulfate
    • +3 more
    • London, England, United Kingdom
    • +1 more
    Sep 19, 2013

    Cancer, Tumors, Lymphoma Trial in Edgbaston, Tremona Road, (Chi Lob 7/4 (A chimeric mAb))

    Completed
    • Cancer
    • +4 more
    • Chi Lob 7/4 (A chimeric monoclonal antibody)
    • Edgbaston, Birmingham, United Kingdom
    • +1 more
    Dec 1, 2014

    Diffuse Large B-cell Lymphoma Trial in Shanghai (DA-EPOCH-R)

    Terminated
    • Diffuse Large B-cell Lymphoma
    • Shanghai, Shanghai, China
      Fudan University Cancer Hospital
    Aug 19, 2014

    Leukemia, Lymphocytic, Chronic, B-Cell Trial in Austria (Lenalidomide, Fludarabine, Rituximab)

    Completed
    • Leukemia, Lymphocytic, Chronic, B-Cell
    • Innsbruck, Tirol, Austria
    • +6 more
    Aug 29, 2013

    Lymphoma Trial in Nottingham (pegfilgrastim, rituximab, cyclophosphamide)

    Unknown status
    • Lymphoma
    • pegfilgrastim
    • +9 more
    • Nottingham, England, United Kingdom
      Nottingham City Hospital
    Aug 23, 2013

    Scleritis, Orbital Disease Trial in Portland (Rituximab)

    Completed
    • Scleritis
    • Orbital Disease
    • Rituximab
    • Portland, Oregon
      Oregon Health & Science University
    Aug 8, 2013

    Anemia, Hemolytic, Autoimmune Trial in Denmark (prednisolone + mabthera, Prednisolone)

    Completed
    • Anemia, Hemolytic, Autoimmune
    • Aalborg, Denmark
    • +10 more
    Sep 9, 2013

    Non-Hodgkin's Lymphoma, Lymphoma Trial in Houston (Rituximab, Zevalin)

    Completed
    • Non-Hodgkin's Lymphoma
    • Lymphoma
    • Houston, Texas
      UT MD Anderson Cancer Center
    Sep 4, 2013

    Lymphoma Trial in Birmingham, Stanford, Rochester (rituximab, yttrium Y 90 ibritumomab tiuxetan)

    Terminated
    • Lymphoma
    • rituximab
    • yttrium Y 90 ibritumomab tiuxetan
    • Birmingham, Alabama
    • +2 more
    Dec 12, 2013

    Lymphoma Trial in Netherlands (filgrastim, rituximab, cyclophosphamide)

    Unknown status
    • Lymphoma
    • filgrastim
    • +5 more
    • 's-Gravenhage, Netherlands
    • +12 more
    Sep 16, 2013

    B-cell Chronic Lymphocytic Leukemia, Leukemia, Prolymphocytic Leukemia Trial in Boston (drug, biological, other)

    Terminated
    • B-cell Chronic Lymphocytic Leukemia
    • +7 more
    • obatoclax mesylate
    • +3 more
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Sep 27, 2013

    Lymphoma Trial in Shanghai (CEOP regimen, CHOP regimen)

    Completed
    • Lymphoma
    • CEOP regimen
    • CHOP regimen
    • Shanghai, Shanghai, China
      Fudan University Cancer Hospital
    Aug 19, 2014

    Recurrent Mantle Cell Lymphoma Trial in United States (rituximab, temsirolimus)

    Completed
    • Recurrent Mantle Cell Lymphoma
    • Mobile, Alabama
    • +194 more
    Mar 21, 2014

    Hematological Malignancies Trial in Pavia

    Unknown status
    • Hematological Malignancies
      • Pavia, Italy
        Department of Hematology Oncology, IRCCS Policlinico San Matteo
      Jun 4, 2015

      Rheumatoid Arthritis Trial in United States (Rituximab)

      Completed
      • Rheumatoid Arthritis
      • Rituximab
      • Fort Lauderdale, Florida
      • +5 more
      Aug 21, 2013

      Lymphoma Trial (biological, genetic, other)

      Unknown status
      • Lymphoma
      • rituximab
      • +6 more
      • (no location specified)
      Aug 1, 2013

      Leukemia, Lymphoma, MDS Trial in Atlanta (biological, drug, procedure)

      Terminated
      • Leukemia
      • +3 more
      • alemtuzumab
      • +8 more
      • Atlanta, Georgia
        Blood and Marrow Transplant Group of Georgia
      Oct 28, 2013

      Lymphoma Trial in United States (rituximab)

      Terminated
      • Lymphoma
      • rituximab
      • Birmingham, Alabama
      • +8 more
      Jun 14, 2013

      Non-Hodgkin Lymphomas Trial in Chicago, Niles, Park Ridge (Ofatumumab)

      Terminated
      • Non-Hodgkin Lymphomas
      • Chicago, Illinois
      • +2 more
      Jul 2, 2014

      END STAGE RENAL DISEASE Trial in Guadalajara (ESW group)

      Completed
      • END STAGE RENAL DISEASE
      • ESW group
      • Guadalajara, Jalisco, Mexico
        Umae Hospital de Especialidades
      Dec 26, 2014

      Leukemia Trial in Rouen (Campath, rituximab, cyclophosphamide)

      Completed
      • Leukemia
      • Campath
      • +3 more
      • Rouen, France
        Centre Henri Becquerel
      Jul 24, 2013